- Home
- BNTC vs NATH Comparison
BNTC vs NATH Comparison
Compare BNTC & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- NATH
- Stock Information
- Founded
- BNTC 1995
- NATH 1916
- Country
- BNTC United States
- NATH United States
- Employees
- BNTC N/A
- NATH N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- BNTC Health Care
- NATH Consumer Discretionary
- Exchange
- BNTC Nasdaq
- NATH Nasdaq
- Market Cap
- BNTC 339.8M
- NATH 330.5M
- IPO Year
- BNTC N/A
- NATH N/A
- Fundamental
- Price
- BNTC $16.11
- NATH $94.23
- Analyst Decision
- BNTC Strong Buy
- NATH
- Analyst Count
- BNTC 7
- NATH 0
- Target Price
- BNTC $24.43
- NATH N/A
- AVG Volume (30 Days)
- BNTC 37.6K
- NATH 13.7K
- Earning Date
- BNTC 05-12-2025
- NATH 02-06-2025
- Dividend Yield
- BNTC N/A
- NATH 2.11%
- EPS Growth
- BNTC N/A
- NATH 24.88
- EPS
- BNTC N/A
- NATH 5.80
- Revenue
- BNTC N/A
- NATH $146,386,000.00
- Revenue This Year
- BNTC N/A
- NATH N/A
- Revenue Next Year
- BNTC N/A
- NATH N/A
- P/E Ratio
- BNTC N/A
- NATH $16.47
- Revenue Growth
- BNTC N/A
- NATH 6.83
- 52 Week Low
- BNTC $4.75
- NATH $64.02
- 52 Week High
- BNTC $15.97
- NATH $104.96
- Technical
- Relative Strength Index (RSI)
- BNTC 70.37
- NATH 49.94
- Support Level
- BNTC $14.90
- NATH $91.40
- Resistance Level
- BNTC $15.97
- NATH $96.39
- Average True Range (ATR)
- BNTC 1.03
- NATH 2.17
- MACD
- BNTC 0.32
- NATH -0.82
- Stochastic Oscillator
- BNTC 85.59
- NATH 29.54
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.